DexCom, Inc.
DXCM
•Stock Analysis$86.33
+0.00 (+0.00%)• Live
DexCom, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for DexCom, Inc.
Key Financial Metrics
for DexCom, Inc.
P/E Ratio
60.65
Revenue Growth
+11.34%
EPS Growth
+1.39%
Market Cap
$32.54B
Dividend Yield
0.00%
Debt/Equity
1.14
ROIC
+9.42%
FCF Yield
+1.77%
View additional metrics
Valuation
P/B Ratio14.32
EV/Sales8.25
Financial Health
Current Ratio1.50
Return on Assets+8.07%
Analyst Recommendations
for DexCom, Inc.
48 analysts
Consensus: Buy
About
for DexCom, Inc.
Company Details
for DexCom, Inc.
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin Ronald Sayer
Employees
10,200
Market Cap
33.85B
Exchange
NASDAQ Global Select
IPO Date
April 14, 2005
Website
www.dexcom.comCIK
0001093557
ISIN
US2521311074
CUSIP
252131107
Country
US
Balance Sheet
for DexCom, Inc.
Cash Flow Statement
for DexCom, Inc.
Income Statement
for DexCom, Inc.
News
No news available at the moment.